These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17229524)

  • 41. Association of BDNF gene polymorphisms with schizophrenia and clinical symptoms in a Chinese population.
    Li W; Zhou N; Yu Q; Li X; Yu Y; Sun S; Kou C; Chen DC; Xiu MH; Kosten TR; Zhang XY
    Am J Med Genet B Neuropsychiatr Genet; 2013 Sep; 162B(6):538-45. PubMed ID: 23832605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.
    Dupré N; Rivière JB; Myers RH; Provencher P; Pourcher E; Emond F; Rouleau GA
    Can J Neurol Sci; 2007 Aug; 34(3):333-5. PubMed ID: 17803032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.
    Kalinderi K; Bostantjopoulou S; Paisan-Ruiz C; Katsarou Z; Hardy J; Fidani L
    Neurosci Lett; 2009 Mar; 452(2):87-9. PubMed ID: 19383421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
    Clarimon J; Eerola J; Hellström O; Tienari PJ; Singleton A
    Neurosci Lett; 2004 Sep; 367(2):168-70. PubMed ID: 15331145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.
    Xu MQ; St Clair D; Ott J; Feng GY; He L
    Schizophr Res; 2007 Mar; 91(1-3):6-13. PubMed ID: 17289348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts.
    Clark LN; Levy G; Tang MX; Mejia-Santana H; Ciappa A; Tycko B; Cote LJ; Louis ED; Mayeux R; Marder K
    Neurosci Lett; 2003 Aug; 347(1):17-20. PubMed ID: 12865131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease.
    Chen CM; Chen IC; Chang KH; Chen YC; Lyu RK; Liu YT; Hu FJ; Chao CY; Lee-Chen GJ; Wu YR
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):458-62. PubMed ID: 17427185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The transcription factor PITX3 is associated with sporadic Parkinson's disease.
    Fuchs J; Mueller JC; Lichtner P; Schulte C; Munz M; Berg D; Wüllner U; Illig T; Sharma M; Gasser T
    Neurobiol Aging; 2009 May; 30(5):731-8. PubMed ID: 17905480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.
    Licinio J; Dong C; Wong ML
    Arch Gen Psychiatry; 2009 May; 66(5):488-97. PubMed ID: 19414708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein E4 and tau allele frequencies among Choctaw Indians.
    Henderson JN; Crook R; Crook J; Hardy J; Onstead L; Carson-Henderson L; Mayer P; Parker B; Petersen R; Williams B
    Neurosci Lett; 2002 May; 324(1):77-9. PubMed ID: 11983299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
    Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
    Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain.
    Green EK; Thaker U; McDonagh AM; Iwatsubo T; Lambert JC; Chartier-Harlin MC; Harris JM; Pickering-Brown SM; Lendon CL; Mann DM
    Neurosci Lett; 2002 May; 324(2):113-6. PubMed ID: 11988340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder.
    Lohoff FW; Weller AE; Bloch PJ; Nall AH; Ferraro TN; Berrettini WH
    J Neural Transm (Vienna); 2008 Sep; 115(9):1339-45. PubMed ID: 18665321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case-Control study of the extended tau gene haplotype in Parkinson's disease.
    Maraganore DM; Hernandez DG; Singleton AB; Farrer MJ; McDonnell SK; Hutton ML; Hardy JA; Rocca WA
    Ann Neurol; 2001 Nov; 50(5):658-61. PubMed ID: 11706972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine.
    Marziniak M; Herzog AL; Mössner R; Sommer C
    J Neural Transm (Vienna); 2008 Sep; 115(9):1321-5. PubMed ID: 18478177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. POLG1 in idiopathic Parkinson disease.
    Tiangyou W; Hudson G; Ghezzi D; Ferrari G; Zeviani M; Burn DJ; Chinnery PF
    Neurology; 2006 Nov; 67(9):1698-700. PubMed ID: 16943369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
    Yu JT; Tan L; Ou JR; Zhu JX; Liu K; Song JH; Sun YP
    Brain Res; 2008 May; 1210():216-22. PubMed ID: 18423577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LRRK2 and Parkinson's disease in Norway.
    Toft M; Haugarvoll K; Ross OA; Farrer MJ; Aasly JO
    Acta Neurol Scand Suppl; 2007; 187():72-5. PubMed ID: 17419834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.